Inactive Instrument

Press Releases Resaphene Suisse AG

Equities

Resaphene Suisse AG: Tinnitus: 4 phases until healing in the Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell	18/20/18	EQ
Resaphene Suisse AG: Correction of the ad hoc announcement dated March 30, 2020 Resaphene Suisse AG has announced the withdrawal of inclusion in the Vienna MTF at the Vienna Stock Exchange	31/20/31	EQ
Resaphene Suisse AG: Resaphene Suisse AG has applied for delisting at the Vienna Stock Exchange	30/20/30	EQ
Resaphene Suisse AG: Charité Ethics Committee in Berlin Approves Study on Tinniwell Tinnitus Therapy	21/20/21	BU
Resaphene Suisse AG: Charité Ethics Committee in Berlin approves study on tinniwell tinnitus therapy	21/20/21	EQ
Resaphene Suisse AG: Breakthrough in Tinnitus Therapy	13/18/13	BU

No results for this search